News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

University of Montana
|
February 23, 2022

As research programs grow at the University of Montana, a team of vaccine scientists are making headway into long-term COVID-19 prevention and clinical trials for an opioid vaccine.

Billings Clinic is participating in a national trial to study the use of an advanced device to treat patients with atrial fibrillation who are at higher risk for stroke and we are enrolling participants now. Called the CHAMPION-AF trial and initiated by Boston Scientific, it is a randomized head-to-head trial designed to evaluate the safety and efficacy of the next-generation WATCHMAN FLX Left Atrial Appendage Closure Device within a broad population of patients with non-valvular atrial fibrillation (AF), including those who are […]

ARTICLES OF INTEREST

Rocky Mountain Life Sciences Investor and Partnering Conference
|
April 7, 2022

Thirty regional companies will be selected to present at the Rocky Mountain Life Sciences Investor & Partnering Conference. Companies seeking seed, early-stage, late-stage funding in the medical device, diagnostic, biotech, pharmaceutical, and digital health sectors are encouraged to apply.

Biotechnology Innovation Organization (BIO)
|
February 25, 2022

With new labeling requirements, bioengineering entered consumer consciousness in a new way this year—but people are learning the benefits, according to Sarah Gallo, BIO’s VP of Agriculture and Environment, in this podcast.

Nine Questions for the World
|
January 4, 2022

From the NIne Questions for the World podcast, December 15, 2021. BIO President Michelle McMurray-Heath is interviewed by Richard Haass.

NEWSLETTER

Newsletter
|
May 6, 2022
Newsletter
|
February 25, 2022

View the Winter II 2022 now!